Activity Director
Department Chairman Endocrinology
Medical Subspecialties Institute
Cleveland Clinic Abu Dhabi
As the Chairman of this year's event, I am profoundly honored to extend a warm welcome to each of you joining us in person. This year, we have curated an enriching program that underscores the strides we have made in the fight against thyroid cancer, as well as the challenges that lie ahead.
In an era marked by rapid advancements in medical science, the significance of staying abreast with the latest research, treatments, and diagnostic approaches cannot be overstated. Thyroid Cancer Update 2024 is designed to foster an environment of learning, sharing, and collaboration among the brightest minds in the field—from seasoned experts to emerging talents.
Our agenda is packed with insightful presentations, and stimulating discussions, all aimed at enhancing our collective expertise and ultimately improving patient outcomes. We are united by a common goal: to push the boundaries of what's possible in thyroid cancer care.
I invite you to immerse yourself in the opportunities that Thyroid Cancer Update 2024 presents. Your participation is not just a testament to your commitment to excellence in healthcare but also a vital contribution to our shared mission of making a tangible difference in the lives of those affected by thyroid cancer.
Let's embark on this journey together, inspired by the knowledge that our collective efforts will continue to shape a brighter future for thyroid cancer care.
Discuss updates for the diagnosis and management of thyroid cancer, especially the use of molecular genomics to provide targeted tyrosine kinase inhibitor therapy.
Staff Physician
Medical Oncology & Hematology
Oncology Institute
Cleveland Clinic Abu Dhabi
Dr. David Grossman, MD FACP, is a Staff Physician in the Hematology Oncology Program in the Oncology Institute at Cleveland Clinic Abu Dhabi.
Prior to joining Cleveland Clinic Abu Dhabi, Dr. Grossman spent 7 years at Cleveland Clinic Florida, US, building the Cancer Center, bringing his years of experience and expertise to a small and excellent program. He helped to build that program to 17 physicians in his time in Florida before coming to Abu Dhabi.
Prior to that, Dr. Grossman was in practice in the Western Suburbs of Philadelphia, US, in a practice affiliated with the University of Pennsylvania. He joined one other physician and grew to 12 physicians in 26 years. The practice took pride in providing the highest level of cancer care in the community, taking care of patients close to their home.
Department Chairman
Otolaryngology (ENT) and Head & Neck Surgery
Surgical Subspecialties Institute
Cleveland Clinic Abu Dhabi
Dr. Mahdi Shkoukani, MD, is the Department Chair for Otolaryngology Head & Neck Surgery department in the Surgical Subspecialties Institute at Cleveland Clinic Abu Dhabi. He is also a Clinical Associate Professor in the Department of Surgery at Cleveland Clinic Learner College of Medicine, Case Western Reserve University. Also, Dr. Shkoukani is the Medical Director for Supply Chain Operations at Cleveland Clinic Abu Dhabi.
Dr. Shkoukani is a double American Board-certified surgeon in Otolaryngology Head and Neck Surgery, as well as in Facial Plastic & Reconstructive Surgery.
Prior to joining Cleveland Clinic Abu Dhabi, Dr. Shkoukani served as an Associate Professor and Chief of Craniofacial Surgery at the Department of Otolaryngology-Head & Neck Surgery at Wayne State University in Detroit, Michigan, US. Additionally, he was the chief of otolaryngology at the John D. Dingell Veteran’s Administration Hospital in Detroit, Michigan, US.
Acting Chair
Pathology and Laboratory Medicine Institute
Cleveland Clinic Abu Dhabi
Dr. Basel Altrabulsi has been part of National Reference Laboratory’s (NRL) scientific leadership team since 2015, in his current role he oversees the pathology and laboratory services at Cleveland Clinic Abu Dhabi. Cleveland Clinic Abu Dhabi is one of NRL’s flagship laboratories in the UAE, specializing in Anatomic Pathology.
Dr. Basel is certified by the American Board of Pathology, combined Clinical and Anatomical Pathology and brings to NRL more than 18 years’ international experience in the field of laboratory medicine and diagnostic pathology.
Dr. Basel started his internship in pathology at Baylor University Medical Center, Dallas, Texas and completed his residency training in 2003. He then completed his Selective Pathology Fellowship, followed by a Clinical Research Training Program, at the University of Texas MD Anderson Cancer Center.
Dr. Basel’s career has included multiple leadership positions at elite US hospitals and reference laboratories, such as Chief of Service and Medical Director at Baylor University Medical Center; Director of the Histology Laboratory at Greater Dallas Pathology; and Medical Director of Arlington Cancer Center. He has also served as an Inspection Team Leader for the College of American Pathologists (CAP) on multiple occasions.
He has authored many research publications and is a member of global organizations, such as the International Society of Urological Pathology, the International Society of Breast Pathology, and the United States and Canadian Academy of Pathology. Dr. Basel is passionate about research and education and is the Pathology Course Director at Khalifa University, College of Medicine and Health Sciences in Abu Dhabi.
Program Manager
Cleveland Clinic Abu Dhabi
Derrick Keddington is a Program Manager at Cleveland Clinic Abu Dhabi based in Abu Dhabi, Abu Dhabi.
Previously, Derrick was a Practice Manager at Oak Street Health and also held positions at University of Utah Health, Duke Health, University of Minnesota, Tanner Clinic, Utah State University, City of Centerville, Utah.
Department Administrator (Manager) – Clinical Operations
Cleveland Clinic Abu Dhabi
Department Administrator (Manager) – Clinical Operations
Cleveland Clinic Abu Dhabi
The planning committee, faculty and others in control of content (either individually or as a group) do not have relevant financial relationships with ineligible companies.
© MCO – Medetarian Conference Organizing | Thyroid Cancer Update 2024